BELLICUM PHARMACEUTICALS, INC (38) | Business Finance (14)
Browse by Subcategory
Recent Contracts
-
Form of accompanying common warrant issued in December 2021 private placement
(Filed With SEC on December 6, 2021)
-
Securities Purchase Agreement, dated December 4, 2021, by and among the Company and the purchasers named therein
(Filed With SEC on December 6, 2021)
-
Underwriting Agreement, dated October 29, 2020, by and between Bellicum Pharmaceuticals and H.C. Wainwright & Co
(Filed With SEC on November 2, 2020)
-
Second Amendment to Loan and Security Agreement, dated March 31, 2020, by and between the Registrant and Oxford Finance LLC
(Filed With SEC on May 7, 2020)
-
Form of pre-funded warrant issued in December 2021 private placement
(Filed With SEC on December 6, 2021)
-
Form of pre-funded warrant
(Filed With SEC on November 2, 2020)
-
Form of warrant to purchase common stock
(Filed With SEC on November 2, 2020)
-
First Amendment to Loan and Security Agreement, dated December 24, 2019, by and between the Registrant and Oxford Finance LLC
(Filed With SEC on March 12, 2020)
-
First Amendment to Asset Purchase Agreement, dated February 21, 2020, by and between the Registrant and The University of Texas M.D. Anderson Cancer Center
(Filed With SEC on March 12, 2020)
-
Asset Purchase Agreement, dated January 17, 2020, by and between the Registrant and The University of Texas M.D. Anderson Cancer Center
(Filed With SEC on March 12, 2020)
-
Underwriting Agreement, dated August 16, 2019, by and among the Company, Jefferies LLC and Wells Fargo Securities, LLC, as representative of the several underwriters identified...
(Filed With SEC on August 19, 2019)
-
Form of Warrant issued in public offering
(Filed With SEC on August 19, 2019)
-
Form of Warrant issued in private placement
(Filed With SEC on August 19, 2019)
-
Securities Purchase Agreement, dated August 16, 2019, by and among the Company and the institutional investors named therein
(Filed With SEC on August 19, 2019)